Status:
TERMINATED
Evaluation of Peri-surgical Results at Short and Mean Terms of the GORE ® Excluder Iliac Branch Endoprosthesis
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Iliac Aneurysm
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The aim of this project is to demonstrate the benefit of the use of aortic iliac branch endoprosthesis in the iliac aneurysms and to avoid the classic complications.
Eligibility Criteria
Inclusion
- High surgical risk:
- Comorbidity cardiopulmonary
- Renal insufficiency
- Hostile abdomen including ascites or portal hypertension
- Anatomic criteria:
- Primitive iliac aneurysm superior to 25 mm without collar
- Primitive iliac length superior to 40 mm
- Primitive iliac distal diameter superior to 14 mm
- Presence of internal iliac collar
- Affiliation to a social security system
Exclusion
- Patient without surgical risk
- Non-respect of the Anatomic criteria
- Patient with known allergy to the materials of the device
- Patient with systemic infection
- Patient with severe renal insufficiency
- Patient unable to complete the oximetry test
- Persons under legal protection
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 26 2018
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03312127
Start Date
August 1 2017
End Date
July 26 2018
Last Update
August 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059